| Literature DB >> 21951756 |
Nicholas Graves1, Adrian G Barnett, Philip Clarke.
Abstract
OBJECTIVE: To quantify randomness and cost when choosing health and medical research projects for funding.Entities:
Mesh:
Year: 2011 PMID: 21951756 PMCID: PMC3181233 DOI: 10.1136/bmj.d4797
Source DB: PubMed Journal: BMJ ISSN: 0959-8138
Impact of variability in review panel members’ scores on funding decisions
| Alternatively awarded | No (%) not originally awarded | No (%) originally awarded | Total No (%) |
|---|---|---|---|
| Never | 1662 (80) | 0 | 1662 (61) |
| Sometimes | 423 (20) | 365 (59) | 788 (29) |
| Always | 0 | 255 (41) | 255 (9) |
| Total | 2085 | 620 | 2705 |

Fig 1 Proportion of grants that were never funded, sometimes funded, and always funded if review panels had seven, nine, or 11 members

Fig 2 Range in ranks for grants assessed by review panel with largest proportion of sometimes funded proposals

Fig 3 Range in ranks for grants assessed by review panel with smallest proportion of sometimes funded proposals
Costs and effectiveness of different sized panels
| Funding process | Total costs ($A) | Grants effectively funded | Increase in cost ($A) | Extra grants effectively funded | Incremental cost effectiveness ratio* ($A) |
|---|---|---|---|---|---|
| 7 panel member | 46 276 513 | 2200 | |||
| 797 258 | 53 | 15 043 | |||
| 9 panel members | 47 073 771 | 2253 | |||
| 797 258 | 43 | 18 541 | |||
| 11 panel members | 47 871 029 | 2296 |
$A1.00 (£0.66; €0.75; $1.10).
*Extra cost per grant effectively funded from choosing next most effective funding process.